Equillium (EQ) Amortizatization of Intangibles (2019 - 2025)
Equillium (EQ) posted quarterly Amortizatization of Intangibles of $14000.0 for Q1 2025, down 94.96% year-over-year from $278000.0 in Q1 2024, and down 79.71% quarter-over-quarter from $69000.0 in Q4 2024.
Powered by 
Analysis
Equillium (EQ) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Equillium (EQ) has reported Amortizatization of Intangibles for 7 consecutive years, with $14000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Amortizatization of Intangibles fell 94.96% year-over-year to $14000.0; the TTM figure through Dec 2025 stood at $14000.0 (down 98.14% YoY), while the FY2025 annual figure was $14000.0, down 98.14% from the prior year.
- Amortizatization of Intangibles eased to $14000.0 in Q1 2025 per EQ's latest filing, from $69000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $301000.0 in Q2 2023 and bottomed at -$105000.0 in Q2 2021.
- Historically, Amortizatization of Intangibles has averaged $73000.0 across 5 years, with a median of $14000.0 in 2025.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles sank 1528.57% — and 2023, when it surged 1257.69%.
- Equillium's Amortizatization of Intangibles stood at -$35000.0 in 2021, then jumped by 31.43% to -$24000.0 in 2022, then soared by 787.5% to $165000.0 in 2023, then plunged by 58.18% to $69000.0 in 2024, then tumbled by 79.71% to $14000.0 in 2025.
- Business Quant data shows EQ's Amortizatization of Intangibles at $14000.0 in Q1 2025, $69000.0 in Q4 2024, and $166000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Equillium | 249.33 Mn | 249.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 278,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Mar 31, 2023 | 296,000.00 |
| Dec 31, 2022 | -24,000.00 |
| Sep 30, 2022 | -30,000.00 |
| Jun 30, 2022 | -26,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Dec 31, 2021 | -35,000.00 |
| Sep 30, 2021 | -74,000.00 |
| Jun 30, 2021 | -105,000.00 |
| Mar 31, 2021 | -100,000.00 |
| Dec 31, 2020 | -74,000.00 |
| Sep 30, 2020 | -22,000.00 |
| Jun 30, 2020 | -15,000.00 |